ACHP Response to RFI on Access to Cell and Gene Therapies
ACHP submitted a response to an RFI from Senator Bill Cassidy (R-LA) on access to cell and gene therapies.
ACHP submitted a response to an RFI from Senator Bill Cassidy (R-LA) on access to cell and gene therapies.
ACHP strongly supports CMS’ proposed CY 2025 Medicare C & D rule, which supports consumer choice and caps broker compensation.
ACHP supports CMS’ proposals to reform broker agent compensation and urges immediate implementation to support and improve the Medicare Advantage and Part D programs.
When people with diabetes follow their prescribed medical regimens, they are at least 30 percent less likely to wind up in the emergency room and at least 24 percent less likely to be admitted into the hospital, according to a new report from ACHP.
ACHP sent a comment letter to CMS on the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs proposed rule.
